USD 3.12
(-11.36%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 22.83 Million USD | -23.8% |
2022 | 29.96 Million USD | 8.22% |
2021 | 27.69 Million USD | -48.62% |
2020 | 53.89 Million USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q3 | 21.03 Million USD | 0.0% |
2024 Q1 | 22.25 Million USD | 0.0% |
2024 Q2 | 21.65 Million USD | 0.0% |
2023 Q2 | 28.69 Million USD | -2.52% |
2023 FY | 22.83 Million USD | -23.8% |
2023 Q1 | 29.44 Million USD | -1.76% |
2023 Q4 | 22.83 Million USD | -2.45% |
2023 Q3 | 23.4 Million USD | -18.43% |
2022 Q2 | 30.42 Million USD | 1.08% |
2022 Q1 | 30.09 Million USD | 8.69% |
2022 FY | 29.96 Million USD | 8.22% |
2022 Q4 | 29.96 Million USD | -0.7% |
2022 Q3 | 30.17 Million USD | -0.81% |
2021 FY | 27.69 Million USD | -48.62% |
2021 Q1 | - USD | -100.0% |
2021 Q4 | 27.69 Million USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 FY | 53.89 Million USD | 0.0% |
2020 Q4 | 53.89 Million USD | 112.31% |
2020 Q3 | 25.38 Million USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott Laboratories | 13.59 Billion USD | 99.832% |
Allurion Technologies Inc. | 2.3 Million USD | -890.243% |
Artivion, Inc. | 305.53 Million USD | 92.526% |
Avanos Medical, Inc. | 159.4 Million USD | 85.674% |
Butterfly Network, Inc. | 22.83 Million USD | 0.0% |
Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 98.08% |
Boston Scientific Corporation | 8.96 Billion USD | 99.745% |
Perspective Therapeutics, Inc. | - USD | -Infinity% |
CONMED Corporation | 971.48 Million USD | 97.649% |
Edwards Lifesciences Corporation | 670 Million USD | 96.592% |
Paragon 28, Inc. | 109.79 Million USD | 79.203% |
Glaukos Corporation | 383.73 Million USD | 94.049% |
Globus Medical, Inc. | 417.4 Million USD | 94.529% |
Inspire Medical Systems, Inc. | 24.84 Million USD | 8.094% |
Integer Holdings Corporation | 959.92 Million USD | 97.621% |
Medtronic plc | 23.87 Billion USD | 99.904% |
Nevro Corp. | 211.47 Million USD | 89.202% |
Owlet, Inc. | 22 Thousand USD | -103695.455% |
Penumbra, Inc. | 220.9 Million USD | 89.663% |
Vicarious Surgical Inc. | 13.78 Million USD | -65.651% |
Smith & Nephew plc | 2.17 Billion USD | 98.95% |
Sonendo, Inc. | 14.03 Million USD | -62.7% |
STERIS plc | 3.12 Billion USD | 99.268% |
Stryker Corporation | 10.9 Billion USD | 99.791% |
Vapotherm, Inc. | 109.97 Million USD | 79.237% |
Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 99.531% |